Results 181 to 190 of about 14,958,381 (308)

Diet quality and anthropometric indices of patients undergone bariatric surgery: the prospective Tehran obesity treatment study. [PDF]

BMC Surg, 2023
Hosseini-Esfahani F, Kazemi-Aliakbar M, Koochakpoor G, Barzin M, Khalaj A, Valizadeh M, Mirmiran P.   +6 more
europepmc   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Intermittent theta burst stimulation (iTBS) and inhibitory control training for excess weight treatment: study protocol for a randomized controlled trial (InhibE). [PDF]

BMC Psychol
Bernat-Villena A, Pérez-Comino FJ, Becerra-Losada M, Algarra-López LS, Caracuel A, Vilar-López R.   +5 more
europepmc   +1 more source

Sample size recalculation based on the prevalence in a randomized test-treatment study. [PDF]

BMC Med Res Methodol, 2022
Hot A, Benda N, Bossuyt PM, Gerke O, Vach W, Zapf A.   +5 more
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Early Prediction Model for Osteoporotic Fracture in Type 2 Diabetes Patients: A Nomogram Approach Based on a Single-Center Retrospective Study

Diabetes, Metabolic Syndrome and Obesity
Peng Fei Liu,1 Yan Xin Ren,1 Peng Wang,2 Xiu Mei Ma,3 Kang Geng4,5 1China Aerospace Science & Industry Corporation 731 hospital, Beijing, People’s Republic of China; 2Chengdu First People’s Hospital, Chengdu Integrated TCM and Western Medicine ...
Liu PF, Ren YX, Wang P, Ma XM, Geng K
doaj  

Relationship Between Intraocular Pressure and the True Rate of Functional and Structural Progression in the United Kingdom Glaucoma Treatment Study. [PDF]

Invest Ophthalmol Vis Sci
Montesano G, Rabiolo A, Ometto G, Crabb DP, Garway-Heath DF.   +4 more
europepmc   +1 more source

Tailoring dissemination strategies to increase evidence-informed policymaking for opioid use disorder treatment: study protocol. [PDF]

Implement Sci Commun, 2023
Crable EL, Grogan CM, Purtle J, Roesch SC, Aarons GA.   +4 more
europepmc   +1 more source

Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers

Molecular Oncology, EarlyView.
This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel, Peyman Zarrineh, Nathnael T. Tuffa, Jigar H. Sheth, Sumitra Mohan, Mudassar Iqbal, Sankari Nagarajan   +6 more
wiley   +1 more source

Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial. [PDF]

PLoS One
Pan H, Li X, Wu S, Zhou D, Guan H, Wu H, Wang Q, Tang Y, Hu X, Wang M, Zhou M, Huang R, Liu L, Chen Y, Wen C, Huang L.   +15 more
europepmc   +1 more source